PURPOSE: To examine the relationship between microaneurysm turnover (formation rate), using a new semi-automatic method (MA-Tracker) based on color fundus photographs, and diabetic retinopathy (DR) progression to clinically significant macular edema (CSME). METHODS: In total, 113 patients/eyes with nonproliferative DR (NPDR) were followed up every 6 months for 2 years as controls of the DR clinical trials, and by conventional general and ophthalmological care for the next 8 years (over a total of 10 years' follow-up). Microaneurysm turnover for the 2 first years was computed using the MA-Tracker. RESULTS: The 17 patients that developed CSME over the 10 years of follow-up presented a microaneurysm formation rate of 9.2 +/- 18.2 microaneurysms/year (mean +/- SD) during the first 2 years, which was statistically higher than the eyes that did not develop CSME (0.5 +/- 1.2 microaneurysms/year, p < 0.001). These 17 patients also presented higher HbA(1C) levels at baseline (8.5 +/- 1.2%) compared to the patients who did not develop CSME (7.3 +/- 1.2%, p = 0.001). CONCLUSIONS: A high microaneurysm formation rate on color fundus photographs appears to be a good biomarker for DR progression to CSME in type 2 diabetic patients with NPDR. (c) 2009 S. Karger AG, Basel.
PURPOSE: To examine the relationship between microaneurysm turnover (formation rate), using a new semi-automatic method (MA-Tracker) based on color fundus photographs, and diabetic retinopathy (DR) progression to clinically significant macular edema (CSME). METHODS: In total, 113 patients/eyes with nonproliferative DR (NPDR) were followed up every 6 months for 2 years as controls of the DR clinical trials, and by conventional general and ophthalmological care for the next 8 years (over a total of 10 years' follow-up). Microaneurysm turnover for the 2 first years was computed using the MA-Tracker. RESULTS: The 17 patients that developed CSME over the 10 years of follow-up presented a microaneurysm formation rate of 9.2 +/- 18.2 microaneurysms/year (mean +/- SD) during the first 2 years, which was statistically higher than the eyes that did not develop CSME (0.5 +/- 1.2 microaneurysms/year, p < 0.001). These 17 patients also presented higher HbA(1C) levels at baseline (8.5 +/- 1.2%) compared to the patients who did not develop CSME (7.3 +/- 1.2%, p = 0.001). CONCLUSIONS: A high microaneurysm formation rate on color fundus photographs appears to be a good biomarker for DR progression to CSME in type 2 diabeticpatients with NPDR. (c) 2009 S. Karger AG, Basel.
Authors: Haiyan Wang; Jay Chhablani; William R Freeman; Candy K Chan; Igor Kozak; Dirk-Uwe Bartsch; Lingyun Cheng Journal: Am J Ophthalmol Date: 2012-02-01 Impact factor: 5.258
Authors: Michael Dubow; Alexander Pinhas; Nishit Shah; Robert F Cooper; Alexander Gan; Ronald C Gentile; Vernon Hendrix; Yusufu N Sulai; Joseph Carroll; Toco Y P Chui; Joseph B Walsh; Rishard Weitz; Alfredo Dubra; Richard B Rosen Journal: Invest Ophthalmol Vis Sci Date: 2014-03-04 Impact factor: 4.799
Authors: Toco Yuen Ping Chui; Alexander Pinhas; Alexander Gan; Moataz Razeen; Nishit Shah; Eric Cheang; Chun L Liu; Alfredo Dubra; Richard B Rosen Journal: Ophthalmic Physiol Opt Date: 2016-01-24 Impact factor: 3.117
Authors: Dawn A Sim; Pearse A Keane; Adnan Tufail; Catherine A Egan; Lloyd Paul Aiello; Paolo S Silva Journal: Curr Diab Rep Date: 2015-03 Impact factor: 5.430
Authors: Ana Rita Santos; Luis Mendes; Maria Helena Madeira; Ines P Marques; Diana Tavares; João Figueira; Conceição Lobo; José Cunha-Vaz Journal: J Clin Med Date: 2021-05-15 Impact factor: 4.241